Insurance stocks are suddenly the cool kids

The glow-up nobody had on the bingo card

Health insurers are having a very real moment. UnitedHealth, Humana, CVS Health, and Elevance Health have all been climbing as the market digests a friendlier Medicare Advantage payment backdrop and a wave of higher guidance.

The driver: more money from Washington

The big spark here is the Trump administration's decision to increase Medicare Advantage payments by 2.48%, or about $13 billion, well above the 0.09% bump that had been proposed. For insurers, that’s not just a nice little bonus — it’s the difference between “we’ll manage” and “we can actually raise the outlook.”

And raise it they did:

• UnitedHealth lifted adjusted EPS guidance to $18.25 from $17.75.
• CVS pushed its full-year profit forecast to $7.30-$7.50, up from $7.00-$7.20.
• Humana and Elevance also nudged up their outlooks.

Wall Street smells opportunity

Analysts are piling on like this is the last seat at a concert. Morgan Stanley raised its UNH target to $468 from $453, Bank of America went to $475, and Leerink came in at $462. CVS and Humana got similar love, with multiple firms lifting price targets above where the stocks were trading.

The valuation pitch is pretty simple: if the earnings picture is improving and the stocks still trade at roughly mid-teens forward P/E multiples, maybe the market was sleeping on them a bit.

What you should watch next

The next real test is earnings, and the calendar is already lined up. UnitedHealth reports on July 16th, Humana on July 29th, and CVS on August 5th. If the numbers back up the new optimism, this rally could keep running. If not, well… rallies built on reimbursement vibes can get jumpy fast.

Big picture: the market is suddenly treating health insurers like a comeback story instead of a cautionary tale, and for once the plot twist came from policy, not a TikTok trend.